Human	B:C0086418
amnion	O
epithelial	O
cells	I:C0014597
rescue	O
cell	O
death	I:C0007587
via	O
immunomodulation	O
of	O
microglia	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

Human	O
amnion	B:C1305379
epithelial	O
cells	I:C0014597
rescue	O
cell	O
death	I:C0007587
via	O
immunomodulation	O
of	O
microglia	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

Human	O
amnion	O
epithelial	B:C0014597
cells	I:C0014597
rescue	O
cell	O
death	I:C0007587
via	O
immunomodulation	O
of	O
microglia	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

Human	O
amnion	O
epithelial	O
cells	I:C0014597
rescue	O
cell	B:C0007587
death	I:C0007587
via	O
immunomodulation	O
of	O
microglia	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

Human	O
amnion	O
epithelial	O
cells	I:C0014597
rescue	O
cell	O
death	I:C0007587
via	O
immunomodulation	B:C1963758
of	O
microglia	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

Human	O
amnion	O
epithelial	O
cells	I:C0014597
rescue	O
cell	O
death	I:C0007587
via	O
immunomodulation	O
of	O
microglia	B:C0206116
in	O
a	O
mouse	O
model	I:C2986594
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

Human	O
amnion	O
epithelial	O
cells	I:C0014597
rescue	O
cell	O
death	I:C0007587
via	O
immunomodulation	O
of	O
microglia	O
in	O
a	O
mouse	B:C2986594
model	I:C2986594
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

Human	O
amnion	O
epithelial	O
cells	I:C0014597
rescue	O
cell	O
death	I:C0007587
via	O
immunomodulation	O
of	O
microglia	O
in	O
a	O
mouse	O
model	I:C2986594
of	O
perinatal	B:C2347482
brain	I:C2347482
injury	I:C2347482
.	O

Human	B:C0086418
amnion	O
epithelial	O
cells	I:C0014597
(	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
)	O
are	O
clonogenic	O
and	O
have	O
been	O
proposed	O
to	O
reduce	O
inflammatory	O
-	O
induced	O
tissue	O
injury	I:C0037578
.	O

Human	O
amnion	B:C1305379
epithelial	O
cells	I:C0014597
(	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
)	O
are	O
clonogenic	O
and	O
have	O
been	O
proposed	O
to	O
reduce	O
inflammatory	O
-	O
induced	O
tissue	O
injury	I:C0037578
.	O

Human	O
amnion	O
epithelial	B:C0014597
cells	I:C0014597
(	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
)	O
are	O
clonogenic	O
and	O
have	O
been	O
proposed	O
to	O
reduce	O
inflammatory	O
-	O
induced	O
tissue	O
injury	I:C0037578
.	O

Human	O
amnion	O
epithelial	O
cells	I:C0014597
(	O
Human	B:C0014597
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
)	O
are	O
clonogenic	O
and	O
have	O
been	O
proposed	O
to	O
reduce	O
inflammatory	O
-	O
induced	O
tissue	O
injury	I:C0037578
.	O

Human	O
amnion	O
epithelial	O
cells	I:C0014597
(	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
)	O
are	O
clonogenic	O
and	O
have	O
been	O
proposed	O
to	O
reduce	O
inflammatory	B:C0021368
-	O
induced	O
tissue	O
injury	I:C0037578
.	O

Human	O
amnion	O
epithelial	O
cells	I:C0014597
(	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
)	O
are	O
clonogenic	O
and	O
have	O
been	O
proposed	O
to	O
reduce	O
inflammatory	O
-	O
induced	O
tissue	B:C0037578
injury	I:C0037578
.	O

Perturbation	O
of	O
the	O
immune	B:C0301872
response	I:C0301872
is	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
;	O
modulating	O
this	O
response	O
could	O
thus	O
be	O
a	O
novel	O
therapy	O
for	O
treating	O
or	O
preventing	O
such	O
injury	O
.	O

Perturbation	O
of	O
the	O
immune	O
response	I:C0301872
is	O
implicated	O
in	O
the	O
pathogenesis	B:C0699748
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
;	O
modulating	O
this	O
response	O
could	O
thus	O
be	O
a	O
novel	O
therapy	O
for	O
treating	O
or	O
preventing	O
such	O
injury	O
.	O

Perturbation	O
of	O
the	O
immune	O
response	I:C0301872
is	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
perinatal	B:C2347482
brain	I:C2347482
injury	I:C2347482
;	O
modulating	O
this	O
response	O
could	O
thus	O
be	O
a	O
novel	O
therapy	O
for	O
treating	O
or	O
preventing	O
such	O
injury	O
.	O

Perturbation	O
of	O
the	O
immune	O
response	I:C0301872
is	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
;	O
modulating	B:C0443264
this	O
response	O
could	O
thus	O
be	O
a	O
novel	O
therapy	O
for	O
treating	O
or	O
preventing	O
such	O
injury	O
.	O

Perturbation	O
of	O
the	O
immune	O
response	I:C0301872
is	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
;	O
modulating	O
this	O
response	B:C0301872
could	O
thus	O
be	O
a	O
novel	O
therapy	O
for	O
treating	O
or	O
preventing	O
such	O
injury	O
.	O

Perturbation	O
of	O
the	O
immune	O
response	I:C0301872
is	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
;	O
modulating	O
this	O
response	O
could	O
thus	O
be	O
a	O
novel	O
therapy	B:C0087111
for	O
treating	O
or	O
preventing	O
such	O
injury	O
.	O

Perturbation	O
of	O
the	O
immune	O
response	I:C0301872
is	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
;	O
modulating	O
this	O
response	O
could	O
thus	O
be	O
a	O
novel	O
therapy	O
for	O
treating	O
or	O
preventing	O
such	O
injury	B:C2347482
.	O

The	O
immunomodulatory	B:C1963758
properties	O
of	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
have	O
been	O
shown	O
in	O
other	O
animal	O
models	I:C0599779
,	O
but	O
a	O
detailed	O
investigation	O
of	O
the	O
effects	O
on	O
brain	O
immune	O
cells	O
following	O
injury	O
has	O
not	O
been	O
undertaken	O
.	O

The	O
immunomodulatory	O
properties	O
of	O
Human	B:C0014597
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
have	O
been	O
shown	O
in	O
other	O
animal	O
models	I:C0599779
,	O
but	O
a	O
detailed	O
investigation	O
of	O
the	O
effects	O
on	O
brain	O
immune	O
cells	O
following	O
injury	O
has	O
not	O
been	O
undertaken	O
.	O

The	O
immunomodulatory	O
properties	O
of	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
have	O
been	O
shown	O
in	O
other	O
animal	B:C0599779
models	I:C0599779
,	O
but	O
a	O
detailed	O
investigation	O
of	O
the	O
effects	O
on	O
brain	O
immune	O
cells	O
following	O
injury	O
has	O
not	O
been	O
undertaken	O
.	O

The	O
immunomodulatory	O
properties	O
of	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
have	O
been	O
shown	O
in	O
other	O
animal	O
models	I:C0599779
,	O
but	O
a	O
detailed	O
investigation	B:C0220825
of	O
the	O
effects	O
on	O
brain	O
immune	O
cells	O
following	O
injury	O
has	O
not	O
been	O
undertaken	O
.	O

The	O
immunomodulatory	O
properties	O
of	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
have	O
been	O
shown	O
in	O
other	O
animal	O
models	I:C0599779
,	O
but	O
a	O
detailed	O
investigation	O
of	O
the	O
effects	O
on	O
brain	B:C0006104
immune	O
cells	O
following	O
injury	O
has	O
not	O
been	O
undertaken	O
.	O

The	O
immunomodulatory	O
properties	O
of	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
have	O
been	O
shown	O
in	O
other	O
animal	O
models	I:C0599779
,	O
but	O
a	O
detailed	O
investigation	O
of	O
the	O
effects	O
on	O
brain	O
immune	O
cells	B:C0007634
following	O
injury	O
has	O
not	O
been	O
undertaken	O
.	O

The	O
immunomodulatory	O
properties	O
of	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
have	O
been	O
shown	O
in	O
other	O
animal	O
models	I:C0599779
,	O
but	O
a	O
detailed	O
investigation	O
of	O
the	O
effects	O
on	O
brain	O
immune	O
cells	O
following	O
injury	B:C2347482
has	O
not	O
been	O
undertaken	O
.	O

Here	O
,	O
we	O
investigate	B:C0220825
the	O
effects	O
of	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
on	O
microglia	O
,	O
the	O
first	O
immune	O
responders	I:C0301872
to	O
injury	O
within	O
the	O
brain	O
.	O

Here	O
,	O
we	O
investigate	O
the	O
effects	O
of	O
Human	B:C0014597
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
on	O
microglia	O
,	O
the	O
first	O
immune	O
responders	I:C0301872
to	O
injury	O
within	O
the	O
brain	O
.	O

Here	O
,	O
we	O
investigate	O
the	O
effects	O
of	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
on	O
microglia	B:C0206116
,	O
the	O
first	O
immune	O
responders	I:C0301872
to	O
injury	O
within	O
the	O
brain	O
.	O

Here	O
,	O
we	O
investigate	O
the	O
effects	O
of	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
on	O
microglia	O
,	O
the	O
first	O
immune	B:C0301872
responders	I:C0301872
to	O
injury	O
within	O
the	O
brain	O
.	O

Here	O
,	O
we	O
investigate	O
the	O
effects	O
of	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
on	O
microglia	O
,	O
the	O
first	O
immune	O
responders	I:C0301872
to	O
injury	B:C2347482
within	O
the	O
brain	O
.	O

Here	O
,	O
we	O
investigate	O
the	O
effects	O
of	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
on	O
microglia	O
,	O
the	O
first	O
immune	O
responders	I:C0301872
to	O
injury	O
within	O
the	O
brain	B:C0006104
.	O

We	O
generated	O
a	O
mouse	B:C2986594
model	I:C2986594
combining	O
neonatal	O
inflammation	O
and	O
perinatal	O
hyperoxia	O
,	O
both	O
of	O
which	O
are	O
risk	O
factors	I:C0035648
associated	O
with	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

We	O
generated	O
a	O
mouse	O
model	I:C2986594
combining	O
neonatal	O
inflammation	B:C0021368
and	O
perinatal	O
hyperoxia	O
,	O
both	O
of	O
which	O
are	O
risk	O
factors	I:C0035648
associated	O
with	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

We	O
generated	O
a	O
mouse	O
model	I:C2986594
combining	O
neonatal	O
inflammation	O
and	O
perinatal	O
hyperoxia	B:C0242706
,	O
both	O
of	O
which	O
are	O
risk	O
factors	I:C0035648
associated	O
with	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

We	O
generated	O
a	O
mouse	O
model	I:C2986594
combining	O
neonatal	O
inflammation	O
and	O
perinatal	O
hyperoxia	O
,	O
both	O
of	O
which	O
are	O
risk	B:C0035648
factors	I:C0035648
associated	O
with	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

We	O
generated	O
a	O
mouse	O
model	I:C2986594
combining	O
neonatal	O
inflammation	O
and	O
perinatal	O
hyperoxia	O
,	O
both	O
of	O
which	O
are	O
risk	O
factors	I:C0035648
associated	O
with	O
perinatal	B:C2347482
brain	I:C2347482
injury	I:C2347482
.	O

On	O
embryonic	B:C0013936
day	O
16	O
we	O
administered	O
lipopolysaccharide	O
(	O
lipopolysaccharide	O
)	O
,	O
or	O
saline	O
(	O
control	O
)	O
,	O
intra-amniotically	O
to	O
C57B	O
l	I:C1521751
/	I:C1521751
6	I:C1521751
J	I:C1521751
mouse	I:C1521751
pups	I:C1521751
.	O

On	O
embryonic	O
day	O
16	O
we	O
administered	B:C1533734
lipopolysaccharide	O
(	O
lipopolysaccharide	O
)	O
,	O
or	O
saline	O
(	O
control	O
)	O
,	O
intra-amniotically	O
to	O
C57B	O
l	I:C1521751
/	I:C1521751
6	I:C1521751
J	I:C1521751
mouse	I:C1521751
pups	I:C1521751
.	O

On	O
embryonic	O
day	O
16	O
we	O
administered	O
lipopolysaccharide	B:C0023810
(	O
lipopolysaccharide	O
)	O
,	O
or	O
saline	O
(	O
control	O
)	O
,	O
intra-amniotically	O
to	O
C57B	O
l	I:C1521751
/	I:C1521751
6	I:C1521751
J	I:C1521751
mouse	I:C1521751
pups	I:C1521751
.	O

On	O
embryonic	O
day	O
16	O
we	O
administered	O
lipopolysaccharide	O
(	O
lipopolysaccharide	B:C0023810
)	O
,	O
or	O
saline	O
(	O
control	O
)	O
,	O
intra-amniotically	O
to	O
C57B	O
l	I:C1521751
/	I:C1521751
6	I:C1521751
J	I:C1521751
mouse	I:C1521751
pups	I:C1521751
.	O

On	O
embryonic	O
day	O
16	O
we	O
administered	O
lipopolysaccharide	O
(	O
lipopolysaccharide	O
)	O
,	O
or	O
saline	O
(	O
control	O
)	O
,	O
intra-amniotically	O
to	O
C57B	B:C1521751
l	I:C1521751
/	I:C1521751
6	I:C1521751
J	I:C1521751
mouse	I:C1521751
pups	I:C1521751
.	O

On	O
postnatal	O
day	O
(	O
P)	O
0	O
,	O
lipopolysaccharide	B:C0023810
pups	O
were	O
placed	O
in	O
hyperoxia	O
(	O
65	O
%	O
oxygen	O
)	O
and	O
control	O
pups	O
in	O
normoxia	O
for	O
14	O
days	O
.	O

On	O
postnatal	O
day	O
(	O
P)	O
0	O
,	O
lipopolysaccharide	O
pups	B:C1521751
were	O
placed	O
in	O
hyperoxia	O
(	O
65	O
%	O
oxygen	O
)	O
and	O
control	O
pups	O
in	O
normoxia	O
for	O
14	O
days	O
.	O

On	O
postnatal	O
day	O
(	O
P)	O
0	O
,	O
lipopolysaccharide	O
pups	O
were	O
placed	O
in	O
hyperoxia	B:C0242706
(	O
65	O
%	O
oxygen	O
)	O
and	O
control	O
pups	O
in	O
normoxia	O
for	O
14	O
days	O
.	O

On	O
postnatal	O
day	O
(	O
P)	O
0	O
,	O
lipopolysaccharide	O
pups	O
were	O
placed	O
in	O
hyperoxia	O
(	O
65	O
%	O
oxygen	B:C0030054
)	O
and	O
control	O
pups	O
in	O
normoxia	O
for	O
14	O
days	O
.	O

Pups	B:C1521751
were	O
given	O
either	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
or	O
saline	O
intravenously	O
on	O
P4	O
.	O

Pups	O
were	O
given	O
either	O
Human	B:C0014597
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
or	O
saline	O
intravenously	O
on	O
P4	O
.	O

Pups	O
were	O
given	O
either	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
or	O
saline	O
intravenously	B:C1737200
on	O
P4	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	B:C0023810
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	B:C0242706
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	B:C1521751
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	B:C0007634
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	B:C1515232
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	B:C0007776
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	B:C0010097
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	B:C0682708
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	B:C0004112
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	B:C0017626
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	B:C0682708
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	B:C0206116
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	B:C0215872
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	B:C0007776
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	B:C0010097
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	B:C0206116
density	O
(	O
Iba1	O
)	O
.	O

At	O
P14	O
,	O
relative	O
to	O
controls	O
,	O
lipopolysaccharide	O
and	O
hyperoxia	O
pups	O
had	O
reduced	O
body	O
weight	O
,	O
increased	O
density	O
of	O
apoptotic	O
cells	O
(	O
TUNEL	O
)	O
in	O
the	O
cortex	O
,	O
striatum	O
and	O
white	O
matter	I:C0682708
,	O
astrocytes	O
(	O
GFAP	O
)	O
in	O
the	O
white	O
matter	I:C0682708
and	O
activated	O
microglia	O
(	O
CD68	O
)	O
in	O
the	O
cortex	O
and	O
striatum	O
,	O
but	O
no	O
change	O
in	O
total	O
microglia	O
density	O
(	O
Iba1	B:C0312586
)	O
.	O

hAEC	B:C0014597
administration	O
rescued	O
the	O
decreased	O
body	O
weight	O
and	O
reduced	O
apoptosis	O
and	O
astrocyte	O
areal	O
coverage	O
in	O
the	O
white	O
matter	I:C0682708
,	O
but	O
increased	O
the	O
density	O
of	O
total	O
and	O
activated	O
microglia	O
.	O

hAEC	O
administration	B:C1533734
rescued	O
the	O
decreased	O
body	O
weight	O
and	O
reduced	O
apoptosis	O
and	O
astrocyte	O
areal	O
coverage	O
in	O
the	O
white	O
matter	I:C0682708
,	O
but	O
increased	O
the	O
density	O
of	O
total	O
and	O
activated	O
microglia	O
.	O

hAEC	O
administration	O
rescued	O
the	O
decreased	O
body	O
weight	O
and	O
reduced	O
apoptosis	B:C0162638
and	O
astrocyte	O
areal	O
coverage	O
in	O
the	O
white	O
matter	I:C0682708
,	O
but	O
increased	O
the	O
density	O
of	O
total	O
and	O
activated	O
microglia	O
.	O

hAEC	O
administration	O
rescued	O
the	O
decreased	O
body	O
weight	O
and	O
reduced	O
apoptosis	O
and	O
astrocyte	B:C0004112
areal	O
coverage	O
in	O
the	O
white	O
matter	I:C0682708
,	O
but	O
increased	O
the	O
density	O
of	O
total	O
and	O
activated	O
microglia	O
.	O

hAEC	O
administration	O
rescued	O
the	O
decreased	O
body	O
weight	O
and	O
reduced	O
apoptosis	O
and	O
astrocyte	O
areal	O
coverage	O
in	O
the	O
white	B:C0682708
matter	I:C0682708
,	O
but	O
increased	O
the	O
density	O
of	O
total	O
and	O
activated	O
microglia	O
.	O

hAEC	O
administration	O
rescued	O
the	O
decreased	O
body	O
weight	O
and	O
reduced	O
apoptosis	O
and	O
astrocyte	O
areal	O
coverage	O
in	O
the	O
white	O
matter	I:C0682708
,	O
but	O
increased	O
the	O
density	O
of	O
total	O
and	O
activated	O
microglia	B:C0206116
.	O

We	O
then	O
stimulated	O
primary	O
microglia	B:C0206116
(	O
CD45	O
(	O
low	O
)	O
CD11	O
b	I:C1136310
(+	O
)	O
)	O
with	O
lipopolysaccharide	O
for	O
24	O
h	O
,	O
followed	O
by	O
co-culture	O
with	O
hAEC	O
conditioned	O
medium	I:C0162518
for	O
48	O
h.	O

We	O
then	O
stimulated	O
primary	O
microglia	O
(	O
CD45	B:C1435882
(	O
low	O
)	O
CD11	O
b	I:C1136310
(+	O
)	O
)	O
with	O
lipopolysaccharide	O
for	O
24	O
h	O
,	O
followed	O
by	O
co-culture	O
with	O
hAEC	O
conditioned	O
medium	I:C0162518
for	O
48	O
h.	O

We	O
then	O
stimulated	O
primary	O
microglia	O
(	O
CD45	O
(	O
low	O
)	O
CD11	B:C1136310
b	I:C1136310
(+	O
)	O
)	O
with	O
lipopolysaccharide	O
for	O
24	O
h	O
,	O
followed	O
by	O
co-culture	O
with	O
hAEC	O
conditioned	O
medium	I:C0162518
for	O
48	O
h.	O

We	O
then	O
stimulated	O
primary	O
microglia	O
(	O
CD45	O
(	O
low	O
)	O
CD11	O
b	I:C1136310
(+	O
)	O
)	O
with	O
lipopolysaccharide	B:C0023810
for	O
24	O
h	O
,	O
followed	O
by	O
co-culture	O
with	O
hAEC	O
conditioned	O
medium	I:C0162518
for	O
48	O
h.	O

We	O
then	O
stimulated	O
primary	O
microglia	O
(	O
CD45	O
(	O
low	O
)	O
CD11	O
b	I:C1136310
(+	O
)	O
)	O
with	O
lipopolysaccharide	O
for	O
24	O
h	O
,	O
followed	O
by	O
co-culture	B:C0282547
with	O
hAEC	O
conditioned	O
medium	I:C0162518
for	O
48	O
h.	O

We	O
then	O
stimulated	O
primary	O
microglia	O
(	O
CD45	O
(	O
low	O
)	O
CD11	O
b	I:C1136310
(+	O
)	O
)	O
with	O
lipopolysaccharide	O
for	O
24	O
h	O
,	O
followed	O
by	O
co-culture	O
with	O
hAEC	B:C0014597
conditioned	O
medium	I:C0162518
for	O
48	O
h.	O

We	O
then	O
stimulated	O
primary	O
microglia	O
(	O
CD45	O
(	O
low	O
)	O
CD11	O
b	I:C1136310
(+	O
)	O
)	O
with	O
lipopolysaccharide	O
for	O
24	O
h	O
,	O
followed	O
by	O
co-culture	O
with	O
hAEC	O
conditioned	B:C0162518
medium	I:C0162518
for	O
48	O
h.	O

hAEC	B:C0014597
conditioned	O
medium	I:C0162518
increased	O
microglial	O
phagocytic	O
activity	I:C0031308
,	O
decreased	O
microglia	O
apoptosis	O
and	O
decreased	O
M1	O
activation	I:C0024426
markers	I:C0024426
(	O
CD86	O
)	O
.	O

hAEC	O
conditioned	B:C0162518
medium	I:C0162518
increased	O
microglial	O
phagocytic	O
activity	I:C0031308
,	O
decreased	O
microglia	O
apoptosis	O
and	O
decreased	O
M1	O
activation	I:C0024426
markers	I:C0024426
(	O
CD86	O
)	O
.	O

hAEC	O
conditioned	O
medium	I:C0162518
increased	O
microglial	B:C0206116
phagocytic	O
activity	I:C0031308
,	O
decreased	O
microglia	O
apoptosis	O
and	O
decreased	O
M1	O
activation	I:C0024426
markers	I:C0024426
(	O
CD86	O
)	O
.	O

hAEC	O
conditioned	O
medium	I:C0162518
increased	O
microglial	O
phagocytic	B:C0031308
activity	I:C0031308
,	O
decreased	O
microglia	O
apoptosis	O
and	O
decreased	O
M1	O
activation	I:C0024426
markers	I:C0024426
(	O
CD86	O
)	O
.	O

hAEC	O
conditioned	O
medium	I:C0162518
increased	O
microglial	O
phagocytic	O
activity	I:C0031308
,	O
decreased	O
microglia	B:C0206116
apoptosis	O
and	O
decreased	O
M1	O
activation	I:C0024426
markers	I:C0024426
(	O
CD86	O
)	O
.	O

hAEC	O
conditioned	O
medium	I:C0162518
increased	O
microglial	O
phagocytic	O
activity	I:C0031308
,	O
decreased	O
microglia	O
apoptosis	B:C0162638
and	O
decreased	O
M1	O
activation	I:C0024426
markers	I:C0024426
(	O
CD86	O
)	O
.	O

hAEC	O
conditioned	O
medium	I:C0162518
increased	O
microglial	O
phagocytic	O
activity	I:C0031308
,	O
decreased	O
microglia	O
apoptosis	O
and	O
decreased	O
M1	B:C0024426
activation	I:C0024426
markers	I:C0024426
(	O
CD86	O
)	O
.	O

hAEC	O
conditioned	O
medium	I:C0162518
increased	O
microglial	O
phagocytic	O
activity	I:C0031308
,	O
decreased	O
microglia	O
apoptosis	O
and	O
decreased	O
M1	O
activation	I:C0024426
markers	I:C0024426
(	O
CD86	B:C1528561
)	O
.	O

Stimulating	O
Human	B:C0014597
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
for	O
24	O
h	O
with	O
lipopolysaccharide	O
did	O
not	O
alter	O
release	O
of	O
cytokines	O
known	O
to	O
modulate	O
microglia	O
activity	O
.	O

Stimulating	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
for	O
24	O
h	O
with	O
lipopolysaccharide	B:C0023810
did	O
not	O
alter	O
release	O
of	O
cytokines	O
known	O
to	O
modulate	O
microglia	O
activity	O
.	O

Stimulating	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
for	O
24	O
h	O
with	O
lipopolysaccharide	O
did	O
not	O
alter	O
release	B:C1963578
of	O
cytokines	O
known	O
to	O
modulate	O
microglia	O
activity	O
.	O

Stimulating	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
for	O
24	O
h	O
with	O
lipopolysaccharide	O
did	O
not	O
alter	O
release	O
of	O
cytokines	B:C0079189
known	O
to	O
modulate	O
microglia	O
activity	O
.	O

Stimulating	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
for	O
24	O
h	O
with	O
lipopolysaccharide	O
did	O
not	O
alter	O
release	O
of	O
cytokines	O
known	O
to	O
modulate	B:C0443264
microglia	O
activity	O
.	O

Stimulating	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
for	O
24	O
h	O
with	O
lipopolysaccharide	O
did	O
not	O
alter	O
release	O
of	O
cytokines	O
known	O
to	O
modulate	O
microglia	B:C0206116
activity	O
.	O

These	O
data	O
demonstrate	O
that	O
Human	B:C0014597
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
can	O
directly	O
immunomodulate	O
brain	O
microglia	O
,	O
probably	O
via	O
release	O
of	O
trophic	O
factors	I:C1579754
.	O

These	O
data	O
demonstrate	O
that	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
can	O
directly	O
immunomodulate	B:C1963758
brain	O
microglia	O
,	O
probably	O
via	O
release	O
of	O
trophic	O
factors	I:C1579754
.	O

These	O
data	O
demonstrate	O
that	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
can	O
directly	O
immunomodulate	O
brain	B:C0006104
microglia	O
,	O
probably	O
via	O
release	O
of	O
trophic	O
factors	I:C1579754
.	O

These	O
data	O
demonstrate	O
that	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
can	O
directly	O
immunomodulate	O
brain	O
microglia	B:C0206116
,	O
probably	O
via	O
release	O
of	O
trophic	O
factors	I:C1579754
.	O

These	O
data	O
demonstrate	O
that	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
can	O
directly	O
immunomodulate	O
brain	O
microglia	O
,	O
probably	O
via	O
release	B:C1963578
of	O
trophic	O
factors	I:C1579754
.	O

These	O
data	O
demonstrate	O
that	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
can	O
directly	O
immunomodulate	O
brain	O
microglia	O
,	O
probably	O
via	O
release	O
of	O
trophic	B:C1579754
factors	I:C1579754
.	O

This	O
observation	B:C0302523
offers	O
promise	O
that	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
may	O
afford	O
therapeutic	O
utility	I:C0087111
in	O
the	O
management	O
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

This	O
observation	O
offers	O
promise	O
that	O
Human	B:C0014597
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
may	O
afford	O
therapeutic	O
utility	I:C0087111
in	O
the	O
management	O
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

This	O
observation	O
offers	O
promise	O
that	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
may	O
afford	O
therapeutic	B:C0087111
utility	I:C0087111
in	O
the	O
management	O
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

This	O
observation	O
offers	O
promise	O
that	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
may	O
afford	O
therapeutic	O
utility	I:C0087111
in	O
the	O
management	B:C0376636
of	O
perinatal	O
brain	I:C2347482
injury	I:C2347482
.	O

This	O
observation	O
offers	O
promise	O
that	O
Human	O
amnion	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
may	O
afford	O
therapeutic	O
utility	I:C0087111
in	O
the	O
management	O
of	O
perinatal	B:C2347482
brain	I:C2347482
injury	I:C2347482
.	O

